Pending FDA approval, the upgraded Prometra Implantable Pump System for the targeted delivery of pain medication will feature MRI compatibility, Flowonix CEO Steve Adler told FierceDrugDelivery in an ...
WINTER SPRINGS, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- Iradimed Corporation (NASDAQ: IRMD), a global leader in innovative medical devices for MRI environments, today announced that the U.S. Food and ...
New York, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report 'Global MRI Compatible IV Infusion Pumps Market 2022-2026' - 41% during the forecast period. Our report ...
The global MRI-Compatible IV Infusion Pump Systems Market is estimated to be valued at USD 322.5 million in 2025 and is projected to reach USD 742.9 million by 2035, registering a compound annual ...
Flowonix, maker of the implantable Prometra infusion pump for chronic pain patients, announced that it has raised $40 million in debt and equity financing, led by private equity fund Élevage Capital ...
WINTER SPRINGS, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- Iradimed Corporation (NASDAQ: IRMD), a global leader in innovative medical devices for MRI environments, today announced that the U.S. Food and ...
Iradimed Corporation announced that it has received FDA 510(k) clearance for its next-generation MRidium® 3870 IV Infusion Pump System, making it the only supplier of non-magnetic MRI-compatible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback